| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.31 | 3e-13 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.25 | 3e-10 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.25 | 4e-10 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.24 | 6e-09 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.24 | 8e-09 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.29 | 4e-08 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.21 | 1e-07 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-07 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.38 | 5e-07 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.25 | 7e-07 |